Abstract
MicroRNAs are small non-coding RNA transcripts that modulate gene expression and translation through target mRNA destabilization and/or inhibition of protein synthesis. Various studies have aimed at elucidation of the role of these small molecules in the regulation of disease activity. Initially, microRNA were believed to merely act as intracellular mediators fine-tuning mRNA translation into proteins. Recently, the first studies have emerged demonstrating that microRNAs are also externalized from cells and transported in body fluids, thereby shuttling genetic information from a donor to a recipient cell. Thus, circulating microRNAs represent attractive non-invasive detectable markers to monitor onset/ progress of diseases. The present article outlines the quantification and biomarker use of microRNAs in various body fluids of patients with cardiac and kidney disease as well as neurological disorders.
Keywords: microRNAs, kidney, heart, brain, exosomes, microvesicles, biomarker.
Current Medicinal Chemistry
Title:Detection and Transport Mechanisms of Circulating microRNAs in Neurological, Cardiac and Kidney Diseases
Volume: 20 Issue: 29
Author(s): J. M. Lorenzen, F. Martino and T. Thum
Affiliation:
Keywords: microRNAs, kidney, heart, brain, exosomes, microvesicles, biomarker.
Abstract: MicroRNAs are small non-coding RNA transcripts that modulate gene expression and translation through target mRNA destabilization and/or inhibition of protein synthesis. Various studies have aimed at elucidation of the role of these small molecules in the regulation of disease activity. Initially, microRNA were believed to merely act as intracellular mediators fine-tuning mRNA translation into proteins. Recently, the first studies have emerged demonstrating that microRNAs are also externalized from cells and transported in body fluids, thereby shuttling genetic information from a donor to a recipient cell. Thus, circulating microRNAs represent attractive non-invasive detectable markers to monitor onset/ progress of diseases. The present article outlines the quantification and biomarker use of microRNAs in various body fluids of patients with cardiac and kidney disease as well as neurological disorders.
Export Options
About this article
Cite this article as:
Lorenzen M. J., Martino F. and Thum T., Detection and Transport Mechanisms of Circulating microRNAs in Neurological, Cardiac and Kidney Diseases, Current Medicinal Chemistry 2013; 20 (29) . https://dx.doi.org/10.2174/0929867311320290008
DOI https://dx.doi.org/10.2174/0929867311320290008 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
CTO in Contemporary PCI
Current Cardiology Reviews Uric Acid and Oxidative Stress
Current Pharmaceutical Design Synthesis, Structural Determination of a New Ocotillol Derivative and its Epimer
Letters in Organic Chemistry The Role of Oxidative Stress in Methamphetamine and MDMA-induced Toxicity
Mini-Reviews in Organic Chemistry Reactive Oxygen-Induced Cardiac Intracellular Pathways During Ischemia and Reperfusion
Current Signal Transduction Therapy Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome
Current Pharmaceutical Design Angiotensin Converting Enzyme 2 Activator (DIZE) Modulates Metabolic Profiles in Mice, Decreasing Lipogenesis
Protein & Peptide Letters Amiodarone Hepatotoxicity
Current Vascular Pharmacology Strategic Leukofiltration in Cardiac Surgery
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Expression and Functions of Vasoactive Substances Regulated by Hypoxia-Inducible Factor-1 in Chronic Hypoxemia
Cardiovascular & Hematological Agents in Medicinal Chemistry Sex Hormones, Metabolic Syndrome and Kidney
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Cardiovascular and Hematological Agents (Executive Editor: Johann Auer)]
Current Pharmaceutical Design Phosphodiesterase-5 Inhibitors: Future Perspectives
Current Pharmaceutical Design Emerging Role of Stem Cells - Derived Exosomes as Valuable Tools for Cardiovascular Therapy
Current Stem Cell Research & Therapy Glycaemic Control in Cardiac Surgery Patients: a Double-Edged Sword
Current Vascular Pharmacology Cilostazol in the Management of Atherosclerosis
Current Vascular Pharmacology Catestatin: A Master Regulator of Cardiovascular Functions
Current Medicinal Chemistry Heparin Oligosaccharides as Potential Therapeutic Agents in Senile Dementia
Current Pharmaceutical Design Statin Treatment and the Natural History of Atherosclerotic-Related Diseases: Pathogenic Mechanisms and the Risk-Benefit Profile
Current Pharmaceutical Design A Survey on Left Ventricle Segmentation Techniques in Cardiac Short Axis MRI
Current Medical Imaging